Skip to content

BHIVA: Rapid, community-based HIV antibody testing 'highly acceptable' (corrected)

High risk of AIDS or death in HIV-positive individuals in South Africa ineligible for antiretrovirals

Public health and not civil liberties should now guide HIV testing policy, says JAMA commentary

BHIVA issues draft sexual and reproductive health guidelines

XDR TB: now more cases than bird flu

Kaletra tablets better tolerated, patient survey finds

Kaletra not associated with raised blood pressure, manufacturer review reports

Australian prosecutions for HIV transmission highlight need for current UK consultations, deadlines approach

Exposure to ARVs in womb does not affect child's mental development, Canadians report

Lowering the threshold — Is there a case for re-evaluating eligibility criteria for ART?

Leading activist chides TB world for complacency in the face of MDR and now XDR-TB

New risk factors for severe liver toxicity identified in largest ever clinical trial-based analysis

Extensively drug-resistant TB (XDR-TB) present throughout the world

Brazil begins negotiations over Kaletra price again

Antenatal cotrimoxazole prophylaxis leads to cost-effective reduction in preterm delivery and neonatal mortality, Zambian study reveals

Second generic abacavir approved for PEPFAR

Fear of increased appetite proves obstacle to adherence in Rwanda

Radioimmunotherapy clears HIV-infected cells in mice